The described invention relates to novel human immunodeficiency virus protease inhibitors, pharmaceutical compositions containing at least one such inhibitor, methods of preparing such inhibitors, and methods of utilizing such inhibitors to treat HIV and HIV-related disorders.
Full Patent: Human Immunodeficiency Virus Protease Inhibitors
FY09-015
Bio Technology (Rx, dev's, sys)
A.k. Ganguly Dipshikha Biswas Sesha Sridevi Alluri Danielle Caroccia Chih-Hung Wang Eun Hee Kang
Shintaro Kaido Director, Technology Commercialization and New Ventures Stevens Institute of Technology skaido@stevens.edu